Development of clinically viable non-muscle myosin II small molecule inhibitors

Journal:

Cell

Published:

2025-07-01

DOI:

10.1016/j.cell.2025.06.006

Affiliations:

11

Authors:

20

Go to article

Institutions	Authors	Share
University of Florida Health (UF Health), United States of America (USA)	7.666667	0.38
Curia, United States of America (USA)	4.000000	0.20
Biologie Cellulaire et Cancer, France	2.000000	0.10
Myosin Therapeutics, United States of America (USA)	1.333333	0.07
NIH National Heart, Lung, and Blood Institute (NHLBI), United States of America (USA)	1.000000	0.05
Michigan State University (MSU), United States of America (USA)	1.000000	0.05
WHM Consulting, United States of America (USA)	1.000000	0.05
JM Sisco Pharma Consulting, United States of America (USA)	1.000000	0.05
BeOne Medicines, China	1.000000	0.05

Interested in Zoology?